“…Herein, we report a number of synthetic amino-1,4-naphthoquinones and homodimer analogs applying the twin-drug approach whose purpose is the production of a more potent and/or selective drug compared to its unique identity. 39–41 To establish an activity–structure relationship in GST inhibition, three precursors of naphthoquinones were used: 2,3-dichloro-1,4-naphthoquinone ( 1 ), 1,4-naphthoquinone ( 2 ), and 2-hydroxi-1,4-naphthoquinone ( 3 ). The choice of these precursor quinones is based on the structure of diospirine, a bis-naphthoquinone, and its derivatives, in which the presence of a chlorine group has been shown to increase the antitumor activity for the amino-1,4-naphthoquinone series.…”